Quick Summary

Red Clover (Trifolium pratense) is a leguminous plant rich in isoflavones, which are plant compounds classified as phytoestrogens with a preference for binding to estrogen receptor beta. It has been studied mainly for its potential to alleviate menopausal symptoms—especially vasomotor symptoms such as hot flashes—and to improve lipid profiles in postmenopausal women. Evidence suggests it may have modest effects on reducing hot flashes and improving certain cardiovascular risk markers. Red Clover is generally considered safe based on clinical trials, with no major adverse effects reported; however, more rigorous studies are needed to confirm efficacy and establish optimal dosing.

What is it?

Red Clover is a perennial flowering plant belonging to the legume family. It contains naturally occurring isoflavones, a class of phytoestrogens that are structurally similar to estrogens found in the human body. These compounds are thought to interact with estrogen receptors, particularly estrogen receptor beta, potentially influencing various estrogen-related physiological processes.

Traditional Uses

Traditionally, Red Clover has been used in herbal medicine to support women’s health, particularly during menopause. It has also been employed for its purported benefits in promoting cardiovascular health and skin vitality, although these uses are mainly supported by preliminary or traditional knowledge rather than strong clinical evidence.

Active Compounds

  • Isoflavones (including formononetin, biochanin A, daidzein, and genistein)
  • Other phytoestrogens

Potential Benefits with Evidence Levels

Menopausal Symptom Relief (Moderate Evidence)

Red Clover isoflavones have been studied for reducing hot flashes and other menopausal symptoms. A systematic review and meta-analysis found a statistically significant reduction in daily hot flush frequency (approximately 1.73 fewer hot flushes per day) and moderate improvements in menopausal symptoms with doses ≥80 mg/day of isoflavones over 12 weeks (Kanadys et al., 2021). Additional meta-analyses support these findings but highlight variability in study quality (Oh MR et al., 2024; Kim JH, Yu HJ, 2025).

Cardiovascular Health – Lipid Profile (Moderate Evidence)

Red Clover isoflavones may modestly improve lipid profiles in postmenopausal women, including lowering total cholesterol and increasing HDL (“good”) cholesterol. This has been documented in a systematic review with meta-analysis (Błaszczuk A et al., 2022) and further supported by evidence grading studies indicating a probable benefit (Chevallier H et al., 2021).

Skin Anti-Aging and Longevity (Insufficient Clinical Evidence)

Preclinical studies suggest Red Clover isoflavones may have potential uses in longevity promotion and skin regeneration. However, these findings are largely experimental and not yet substantiated in human clinical trials (Gościniak A et al., 2026).

Side Effects

Red Clover is generally well tolerated. Mild adverse effects reported include gastrointestinal discomfort, skin reactions, and rare reproductive system-related symptoms. There are some reports of postmenopausal bleeding potentially associated with Red Clover use, particularly in sensitive individuals. No severe adverse effects have been documented in clinical trials at isoflavone doses ≥80 mg/day.

Drug Interactions

No strong clinical evidence indicates harmful interactions between Red Clover and pharmaceuticals. Nevertheless, theoretical concerns exist regarding possible interactions with hormone therapies, anticoagulants (blood thinners), and medications metabolized through cytochrome P450 enzymes. Caution is advised when Red Clover is taken concurrently with hormone-sensitive drugs.

Who Should Avoid It

Women with hormone-sensitive cancers or disorders, or those using hormone replacement therapy, should avoid or closely monitor Red Clover use unless directed by their healthcare provider. Additionally, use during pregnancy and breastfeeding is generally not recommended due to insufficient safety data and Red Clover’s phytoestrogenic activity.

Evidence Limitations

Most clinical studies on Red Clover have limitations including small sample sizes, short durations (typically 12 weeks), and inconsistencies in isoflavone dosing and extract standardization. These factors restrict the ability to draw definitive conclusions on Red Clover’s efficacy and safety. Further large, high-quality randomized controlled trials with longer follow-up are needed. Evidence beyond menopausal symptom relief, particularly regarding cardiovascular and skin health effects, remains preliminary or preclinical.

References

  • Kanadys W, Barańska A, Błaszczuk A, et al. (2021). Evaluation of Clinical Meaningfulness of Red Clover (Trifolium pratense L.) Extract to Relieve Hot Flushes and Menopausal Symptoms in Peri- and Post-Menopausal Women: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. PMID: 33920485
  • Błaszczuk A, Barańska A, Kanadys W, et al. (2022). Role of Phytoestrogen-Rich Bioactive Substances (Linum usitatissimum L., Glycine max L., Trifolium pratense L.) in Cardiovascular Disease Prevention in Postmenopausal Women: A Systematic Review and Meta-Analysis. PMID: 35745197
  • Chevallier H, Herpin F, Kergosien H, Ventura G, Allaert FA. (2021). A Graded Approach for Evaluating Health Claims about Plant-Based Food Supplements: Application of a Case Study Methodology. PMID: 34444844
  • Oh MR, Park JH, Park SK, Park SH. (2024). Efficacy of Plant-Derived Dietary Supplements in Improving Overall Menopausal Symptoms in Women: An Updated Systematic Review and Meta-Analysis. PMID: 38189863
  • Kim JH, Yu HJ. (2025). Nonpharmacological Intervention Effects on Middle-Aged Women with Menopausal Symptoms: A Systematic Review and Meta-Analysis. PMID: 41464280
  • Tjeerdsma AM, van Hunsel FPAM, van de Koppel S, Ekhart C, Vitalone A, Woerdenbag HJ. (2023). Analysis of Safety Concerns on Herbal Products with Assumed Phytoestrogenic Activity. PMID: 37631050
  • Gościniak A, et al. (2026). Preclinical Review on Anti-Aging and Skin Regenerative Applications of Red Clover Isoflavones. PMCID: PMC12944059

Last Reviewed

June 2024

Disclaimer: This page is for informational purposes only and does not constitute medical advice. The information herein is based on current scientific evidence available at the time of last review. Always consult a qualified healthcare professional before starting any new herbal supplement, especially if you are pregnant, breastfeeding, have underlying health conditions, or are taking medications.